Skip to main content
HRES 484 117th Congress House

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Introduced: June 17, 2021 Introduced by: Miller-Meeks, Mariannette Republican · Iowa See on congress.gov
Commerce Cardiovascular and respiratory healthCompetitiveness, trade promotion, trade deficitsEmergency medical services and trauma careHealth technology, devices, supplies
More subjectsShow fewer subjects
Immunology and vaccinationInfectious and parasitic diseasesIntellectual propertyManufacturing
Sign in to write a letter Sign in to watch
This resolution expired with the 117th Congress
It was not agreed to before the 117th Congress (2021–2022) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Agreed to (House)
Nov 1, 2022
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Jun 17, 2021
Referred to the House Committee on the Judiciary.
Jun 17, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 1, 2022

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

 Plain-English summary Congressional Research Service

This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 23
All 23 Republican 19
R
Bost, Mike
Illinois · Jul 20, 2021
 R
Jackson, Ronny
Texas · Jun 24, 2021
 R
Comer, James
Kentucky · Jun 23, 2021
 R
Budd, Ted
North Carolina · Jun 17, 2021
 R
Burchett, Tim
Tennessee · Jun 17, 2021
Cheney, Liz
· Jun 17, 2021
Duncan, Jeff
· Jun 17, 2021
 R
Emmer, Tom
Minnesota · Jun 17, 2021
 R
Fischbach, Michelle
Minnesota · Jun 17, 2021
 R
Franklin, Scott
Florida · Jun 17, 2021
Gibbs, Bob
· Jun 17, 2021
 R
Green, Mark E.
Texas · Jun 17, 2021
Hice, Jody
· Jun 17, 2021
 R
Hinson, Ashley
Iowa · Jun 17, 2021
 R
Hudson, Richard
North Carolina · Jun 17, 2021
 R
Jordan, Jim
Ohio · Jun 17, 2021
 R
Mace, Nancy
South Carolina · Jun 17, 2021
 R
Malliotakis, Nicole
New York · Jun 17, 2021
 R
Norman, Ralph
South Carolina · Jun 17, 2021
 R
Owens, Burgess
Utah · Jun 17, 2021
 R
Rutherford, John H.
Florida · Jun 17, 2021
 R
Van Drew, Jefferson
New Jersey · Jun 17, 2021
 R
Wagner, Ann
Missouri · Jun 17, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 484: Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.. 117th Congress. Open America. https://openamerica.io/bill/117-HRES-484/
MLA
"H. Res. 484: Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HRES-484/.
Bluebook (legal)
H. Res. 484, 117th Cong. (2026), https://openamerica.io/bill/117-HRES-484/.
Markdown link
[H. Res. 484: Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.](https://openamerica.io/bill/117-HRES-484/)
Report a problem